Samsung invests in Flagship Pioneering Fund VIII
Seoul, Korea, July 11, 2024 – Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis and Samsung Venture Investment Corporation (collectively hereinafter referred to as “Samsung”) announced today an investment into Flagship Pioneering Fund VIII...
Zur Pressemeldung auf news.samsungcnt.com